A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer

Clinical trial NCT02840994 · COMPLETED

Trial details

NCT number: NCT02840994
Sponsor: Bavarian Nordic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2016-12-01
Primary completion: 2020-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.